These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
5. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells. Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899 [TBL] [Abstract][Full Text] [Related]
6. Cordycepin inhibits lipopolysaccharide-induced cell migration and invasion in human colorectal carcinoma HCT-116 cells through down-regulation of prostaglandin E2 receptor EP4. Jeong JW; Park C; Cha HJ; Hong SH; Park SH; Kim GY; Kim WJ; Kim CH; Song KS; Choi YH BMB Rep; 2018 Oct; 51(10):532-537. PubMed ID: 30269738 [TBL] [Abstract][Full Text] [Related]
7. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation in NSCLC Development]. Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway. Xu S; Zhou W; Ge J; Zhang Z Mol Med Rep; 2018 Mar; 17(3):4702-4712. PubMed ID: 29328471 [TBL] [Abstract][Full Text] [Related]
9. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs. Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017 [TBL] [Abstract][Full Text] [Related]
10. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors. Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947 [TBL] [Abstract][Full Text] [Related]
11. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation. Majumder M; Landman E; Liu L; Hess D; Lala PK Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698 [TBL] [Abstract][Full Text] [Related]
12. Combination of EP Wang Y; Cui L; Georgiev P; Singh L; Zheng Y; Yu Y; Grein J; Zhang C; Muise ES; Sloman DL; Ferguson H; Yu H; Pierre CS; Dakle PJ; Pucci V; Baker J; Loboda A; Linn D; Brynczka C; Wilson D; Haines BB; Long B; Wnek R; Sadekova S; Rosenzweig M; Haidle A; Han Y; Ranganath SH Oncoimmunology; 2021 Mar; 10(1):1896643. PubMed ID: 33796403 [TBL] [Abstract][Full Text] [Related]
13. Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer. Doherty GA; Byrne SM; Molloy ES; Malhotra V; Austin SC; Kay EW; Murray FE; Fitzgerald DJ BMC Cancer; 2009 Jun; 9():207. PubMed ID: 19558693 [TBL] [Abstract][Full Text] [Related]
14. Induction of cyclooxygenase-2 expression by prostaglandin E2 stimulation of the prostanoid EP4 receptor via coupling to Gαi and transactivation of the epidermal growth factor receptor in HCA-7 human colon cancer cells. Yoshida K; Fujino H; Otake S; Seira N; Regan JW; Murayama T Eur J Pharmacol; 2013 Oct; 718(1-3):408-17. PubMed ID: 23973650 [TBL] [Abstract][Full Text] [Related]
15. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition. Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001 [TBL] [Abstract][Full Text] [Related]
16. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model. Parida S; Parekh A; Dey G; Ghosh SC; Mandal M Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216 [TBL] [Abstract][Full Text] [Related]
17. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis. Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway. Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834 [TBL] [Abstract][Full Text] [Related]
19. EP4 receptor as a novel promising therapeutic target in colon cancer. Karpisheh V; Joshi N; Zekiy AO; Beyzai B; Hojjat-Farsangi M; Namdar A; Edalati M; Jadidi-Niaragh F Pathol Res Pract; 2020 Dec; 216(12):153247. PubMed ID: 33190014 [TBL] [Abstract][Full Text] [Related]
20. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway. Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]